Results 121 to 130 of about 42,899 (196)

Comparison of 2 stereotactic radiotherapy regimens for brain metastases: Is higher always better? [PDF]

Neurooncol Adv
Bourbonne V, Morjani M, Dissaux B, Cabaret M, Querellou S, Seizeur R, Descourt R, Pradier O, Dissaux G, Lucia F.   +9 more
europepmc   +1 more source

Precision Stereotactic Body Radiotherapy for Ultra‐Central NSCLC: Tailored Margins Reduce Toxicity Without Compromising Tumor Control

MedComm, Volume 7, Issue 8, August 2026.
A tailored non‐uniform PTV strategy (including PTVcrop and PTV_high/PTV_low) was used in SBRT for ultra‐central NSCLC to meet stringent OAR constraints. Notably, this SBRT strategy achieved favorable clinical outcomes, with an 84.6% 3‐year local control rate, a median PFS of 42.9 months. Additionally, treatment‐related toxicity was mild, with only 1.5%
Di Liu, Shuangyan Yang, Yun Chen, Ming Liu, Ruifeng Zhao, Minren Hu, Bin Su, QiongYa Wu, Hongyu Wu, Hui Liu, Jinming Yu, Yaping Xu   +11 more
wiley   +1 more source

Editorial Expression of Concern: The occurrence and development of radiation-induced lung injury after interstitial brachytherapy and stereotactic radiotherapy in SD rats. [PDF]

J Inflamm (Lond)
Chen Z, Wang B, Wu Z, Xiao H, Yang Y, Fan J, Gu Y, Chen C, Wu J.   +8 more
europepmc   +1 more source

Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy

MedComm, Volume 7, Issue 8, August 2026.
Barrier‐defined strategies for cold‐to‐hot tumor conversion. Cold tumors include immune‐desert and immune‐excluded states marked by poor antigen visibility, limited T‐cell priming, stromal or vascular exclusion, metabolic stress and suppressive immune programs.
Xiao Ge, Dong Han, Jing Wang, Xinyu Dai, Chen Ma, Feihong Chen   +5 more
wiley   +1 more source

Multicenter evaluation of planning quality in intracranial stereotactic radiotherapy for brain metastases. [PDF]

Phys Imaging Radiat Oncol
Abdollahi S, Boucenna R, Chatelain C, Corradini N, Fargier-Voiron M, Fave V, Garcia J, Ghandour S, Guckenberger M, Haller K, Härtig M, Hertel T, Jaccard M, Klöck S, Krayenbühl J, López NR, Logaritsch P, Pemler P, Petermann H, Pisaturo O, Pupillo F, Schmidhalter D, Tata C, Thengumpallil S, Vallet V, Weber P, Andratschke N, Tanadini-Lang S.   +27 more
europepmc   +1 more source

Feasibility of convection‐enhanced delivery of unlabeled 225Ac for glioblastoma: Transport, dosimetry, and clonogenic survival modeling

Medical Physics, Volume 53, Issue 8, August 2026.
Abstract Background Glioblastoma (GB) is an aggressive primary brain tumor with local recurrence rates exceeding 90% and a five‐year survival rate of approximately 5%. Standard treatments such as surgical resection, external beam radiotherapy (EBRT), and chemotherapy often leave residual tumor cells that are resistant to therapy.
Maram El Sabri, Leyla Moghaddasi, Puthenparampil Wilson, Frank Saran, Eva Bezak   +4 more
wiley   +1 more source

Volumetric and Linear Imaging Response After Stereotactic Radiotherapy for Vestibular Schwannoma. [PDF]

Cureus
Rocha EM, Costa PT, Arantes M, Aguiar A, Pires A, Conde S.   +5 more
europepmc   +1 more source

Photon minibeam‐based LATTICE radiotherapy for small and medium‐sized tumors: A dosimetric planning study

Medical Physics, Volume 53, Issue 8, August 2026.
Abstract Background Lattice radiotherapy (LRT) is a spatially fractionated technique that delivers three‐dimensional high‐dose vertices within tumors. However, conventional LRT is constrained by geometric limitations when applied to small and medium‐sized tumor volumes, primarily due to the large beam sizes that restrict optimal lattice pattern ...
Wei Wu, Nimita Shinde, Jiaxin Li, Isabelle Vanhaezebrouck, Kai Jiang, Yuting Lin, Qiang Li, Hao Gao   +7 more
wiley   +1 more source

Modeling dose to normal brain following hypofractionated stereotactic radiotherapy to a single brain metastasis. [PDF]

J Appl Clin Med Phys
Johns E, Hargrave C, Nissen L, Barry TJ, Bernard A, Pinkham MB.   +5 more
europepmc   +1 more source

Translational tumor control probability modeling for NSCLC: A two‐dimensional maximum‐likelihood framework

Medical Physics, Volume 53, Issue 8, August 2026.
Abstract Background Tumor control probability (TCP) modeling for early‐stage non‐small cell lung cancer (NSCLC) is usually performed by one‐dimensional (1D) fitting that assumes error‐free dose and assigns all uncertainty to the local control (LC) axis.
Ryoichi Hinoto, Takeji Sakae, Kenta Takada, Takahisa Eriguchi, Masashi Mizumoto, Atsuya Takeda, Hideyuki Sakurai   +6 more
wiley   +1 more source